Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Adit Ginde

Concepts (655)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Emergency Service, Hospital
93
2026
2310
8.060
 Why?
Outpatients
17
2025
442
4.910
 Why?
Critical Illness
28
2026
891
4.710
 Why?
Hospitalization
63
2026
2433
4.020
 Why?
Sepsis
21
2024
640
3.910
 Why?
Intubation, Intratracheal
24
2026
320
3.820
 Why?
Vitamin D
22
2025
400
3.240
 Why?
Vitamin D Deficiency
14
2021
186
2.670
 Why?
Wounds and Injuries
12
2026
956
2.510
 Why?
Influenza, Human
17
2026
616
2.360
 Why?
Adult
177
2026
40449
2.340
 Why?
Emergency Medicine
14
2025
261
2.310
 Why?
Hyperoxia
5
2026
99
2.300
 Why?
Humans
315
2026
144759
2.270
 Why?
Aged
131
2026
25913
2.260
 Why?
Oxygen
15
2026
995
2.250
 Why?
Antiviral Agents
11
2026
767
2.200
 Why?
Cholecalciferol
7
2024
60
2.150
 Why?
Middle Aged
156
2026
35875
2.130
 Why?
Hospital Mortality
23
2025
1030
2.100
 Why?
Emergency Medical Services
15
2025
696
2.060
 Why?
Antibodies, Monoclonal
12
2025
1519
2.030
 Why?
United States
105
2026
15966
2.010
 Why?
Antibodies, Neutralizing
10
2025
340
2.000
 Why?
Influenza Vaccines
15
2026
529
2.000
 Why?
Physician Assistants
7
2014
102
1.990
 Why?
Laryngoscopy
10
2025
117
1.970
 Why?
Patient Discharge
11
2022
983
1.970
 Why?
Length of Stay
22
2026
1337
1.950
 Why?
Respiration, Artificial
12
2026
708
1.840
 Why?
Laryngoscopes
9
2025
45
1.760
 Why?
Male
182
2026
72315
1.750
 Why?
Oxygen Inhalation Therapy
7
2026
182
1.680
 Why?
Ritonavir
3
2023
75
1.660
 Why?
Respiratory Tract Infections
8
2025
397
1.630
 Why?
Female
178
2026
78271
1.590
 Why?
Hospitals
9
2023
730
1.580
 Why?
Intensive Care Units
12
2026
916
1.530
 Why?
Adenosine Monophosphate
7
2026
86
1.510
 Why?
Patient Transfer
5
2015
206
1.470
 Why?
Alanine
6
2025
171
1.420
 Why?
Wound Infection
3
2026
56
1.340
 Why?
Patient Readmission
5
2022
758
1.290
 Why?
Antibodies, Viral
8
2025
672
1.290
 Why?
Health Services Accessibility
11
2019
1098
1.270
 Why?
Vitamins
8
2025
178
1.250
 Why?
Cross-Sectional Studies
35
2025
5868
1.210
 Why?
Retrospective Studies
47
2026
17066
1.190
 Why?
Respiratory Syncytial Virus Infections
6
2026
136
1.180
 Why?
Aged, 80 and over
37
2025
8265
1.160
 Why?
Adolescent
67
2026
22428
1.150
 Why?
Health Care Rationing
2
2024
59
1.150
 Why?
Patient Admission
7
2017
218
1.120
 Why?
Nursing Homes
3
2015
172
1.100
 Why?
Vaccination
23
2026
1423
1.080
 Why?
Young Adult
49
2026
14105
1.040
 Why?
Neuromuscular Nondepolarizing Agents
2
2026
32
1.020
 Why?
Clinical Trials as Topic
5
2026
1053
1.020
 Why?
Brain Injuries, Traumatic
2
2023
441
1.020
 Why?
Androstanols
2
2026
30
1.020
 Why?
Rural Health Services
8
2020
141
1.010
 Why?
Hydroxychloroquine
3
2022
63
1.000
 Why?
Physicians
10
2023
939
1.000
 Why?
Health Care Surveys
17
2020
539
1.000
 Why?
Treatment Outcome
36
2026
11679
0.990
 Why?
Medicaid
4
2015
461
0.990
 Why?
Referral and Consultation
7
2026
851
0.980
 Why?
Airway Management
3
2024
79
0.960
 Why?
Pneumonia
5
2021
631
0.960
 Why?
Diabetes Mellitus
7
2024
1098
0.920
 Why?
Nurse Practitioners
4
2012
140
0.910
 Why?
Rehabilitation Centers
2
2015
39
0.900
 Why?
Stroke
6
2025
1256
0.890
 Why?
Mass Screening
7
2012
1347
0.860
 Why?
Hypoxia
9
2026
1199
0.840
 Why?
Insurance, Health
5
2020
302
0.810
 Why?
Warfare
2
2026
101
0.800
 Why?
Shock, Traumatic
1
2023
15
0.780
 Why?
Medically Uninsured
3
2014
129
0.780
 Why?
Asthma
11
2012
1767
0.750
 Why?
Potentially Inappropriate Medication List
1
2022
16
0.730
 Why?
Randomized Controlled Trials as Topic
19
2026
1720
0.710
 Why?
Military Personnel
4
2023
741
0.710
 Why?
Minority Groups
2
2023
282
0.710
 Why?
Health Services Needs and Demand
3
2013
280
0.710
 Why?
Brain Ischemia
4
2025
358
0.700
 Why?
Inappropriate Prescribing
1
2022
63
0.690
 Why?
Double-Blind Method
19
2026
2029
0.690
 Why?
Pneumonia, Viral
6
2020
384
0.680
 Why?
Prospective Studies
25
2025
7990
0.670
 Why?
Coronavirus Infections
6
2020
378
0.670
 Why?
Primary Health Care
6
2019
1733
0.670
 Why?
Surgical Procedures, Operative
3
2025
270
0.670
 Why?
Respiratory Syncytial Virus Vaccines
3
2025
39
0.660
 Why?
Internship and Residency
8
2023
1257
0.660
 Why?
Patient Outcome Assessment
2
2021
134
0.660
 Why?
Age Factors
13
2025
3333
0.630
 Why?
Severity of Illness Index
14
2026
2925
0.620
 Why?
Acute Kidney Injury
6
2025
865
0.620
 Why?
Career Choice
3
2010
237
0.620
 Why?
Resuscitation Orders
2
2019
47
0.610
 Why?
Multicenter Studies as Topic
9
2026
405
0.610
 Why?
Substance Abuse Detection
1
2021
106
0.610
 Why?
Pandemics
11
2023
1694
0.600
 Why?
Tracheostomy
1
2021
142
0.600
 Why?
Cohort Studies
18
2025
5960
0.590
 Why?
Personnel Selection
2
2010
93
0.590
 Why?
Spine
1
2021
182
0.590
 Why?
Dietary Supplements
8
2025
576
0.580
 Why?
Translating
2
2010
50
0.580
 Why?
Point-of-Care Systems
4
2025
187
0.570
 Why?
Critical Care
5
2022
695
0.560
 Why?
Electronic Health Records
6
2026
1173
0.560
 Why?
Machine Learning
1
2024
585
0.560
 Why?
Resuscitation
1
2021
302
0.560
 Why?
Triage
3
2020
249
0.550
 Why?
Influenza A Virus, H1N1 Subtype
3
2025
157
0.550
 Why?
Conservative Treatment
1
2018
44
0.550
 Why?
Acute Disease
11
2025
1030
0.540
 Why?
Communication Barriers
2
2010
124
0.530
 Why?
Sex Factors
11
2026
2112
0.530
 Why?
Anxiety
1
2025
1109
0.530
 Why?
Brain Injuries
1
2023
507
0.520
 Why?
Health Surveys
4
2014
518
0.520
 Why?
Influenza A Virus, H3N2 Subtype
4
2025
50
0.510
 Why?
Guideline Adherence
6
2022
589
0.510
 Why?
Interdisciplinary Studies
1
2016
29
0.500
 Why?
Financing, Organized
1
2016
36
0.490
 Why?
Professional Autonomy
2
2014
32
0.490
 Why?
MicroRNAs
3
2017
701
0.480
 Why?
Colorado
11
2025
4564
0.480
 Why?
Obesity
4
2022
3077
0.480
 Why?
Anti-Infective Agents
2
2022
242
0.480
 Why?
Skilled Nursing Facilities
2
2016
151
0.470
 Why?
Language
2
2010
321
0.470
 Why?
Surveys and Questionnaires
11
2025
6048
0.470
 Why?
Orthopedics
1
2018
169
0.470
 Why?
Databases, Factual
10
2021
1486
0.460
 Why?
Noninvasive Ventilation
3
2025
62
0.460
 Why?
Oxazines
2
2026
37
0.460
 Why?
Home Care Services
2
2016
280
0.460
 Why?
Antibodies, Monoclonal, Humanized
4
2022
985
0.460
 Why?
Boston
8
2010
92
0.460
 Why?
Risk Factors
17
2026
10779
0.450
 Why?
Emergencies
3
2015
175
0.450
 Why?
Communication
2
2014
965
0.450
 Why?
Multiple Trauma
1
2016
116
0.440
 Why?
Insurance Coverage
3
2016
239
0.440
 Why?
Homes for the Aged
1
2015
32
0.440
 Why?
Healthcare Disparities
3
2012
727
0.440
 Why?
Calcitriol
3
2025
58
0.430
 Why?
Halfway Houses
1
2014
2
0.430
 Why?
Cross Infection
2
2020
262
0.430
 Why?
Hyperglycemia
2
2009
375
0.430
 Why?
Catheterization, Central Venous
1
2016
122
0.420
 Why?
Pilot Projects
7
2023
1886
0.420
 Why?
Acute Lung Injury
3
2025
303
0.420
 Why?
Shock, Septic
4
2018
216
0.420
 Why?
Case-Control Studies
15
2026
3604
0.410
 Why?
Organ Dysfunction Scores
3
2024
53
0.410
 Why?
Oximetry
3
2026
126
0.400
 Why?
Systemic Inflammatory Response Syndrome
1
2014
96
0.400
 Why?
Nutrition Surveys
6
2011
282
0.400
 Why?
Renin-Angiotensin System
2
2025
78
0.400
 Why?
Patient Compliance
3
2008
588
0.400
 Why?
Betacoronavirus
3
2020
286
0.390
 Why?
Faculty, Medical
1
2016
302
0.390
 Why?
Urban Health Services
5
2020
70
0.390
 Why?
Hospitals, Rural
2
2010
51
0.390
 Why?
Research Design
5
2026
1135
0.380
 Why?
Hypoglycemia
2
2008
477
0.380
 Why?
Time Factors
16
2025
7173
0.380
 Why?
International Educational Exchange
1
2012
11
0.380
 Why?
Positive-Pressure Respiration
3
2025
112
0.380
 Why?
Logistic Models
8
2024
2117
0.380
 Why?
California
5
2019
475
0.380
 Why?
Health Knowledge, Attitudes, Practice
4
2025
1414
0.370
 Why?
Opioid-Related Disorders
1
2021
600
0.370
 Why?
Odds Ratio
6
2018
1075
0.370
 Why?
International Classification of Diseases
2
2014
147
0.360
 Why?
Inflammatory Bowel Diseases
1
2017
365
0.360
 Why?
Health Resources
1
2013
129
0.360
 Why?
Biomarkers
12
2026
4271
0.360
 Why?
Medicare
3
2015
886
0.360
 Why?
Renal Dialysis
1
2016
462
0.360
 Why?
Treatment Failure
6
2022
365
0.360
 Why?
Analgesics, Opioid
1
2021
1143
0.360
 Why?
Multivariate Analysis
6
2016
1539
0.350
 Why?
Observation
1
2011
54
0.350
 Why?
Hospital Units
1
2011
32
0.350
 Why?
Patient Education as Topic
4
2010
780
0.340
 Why?
Inflammation Mediators
1
2014
509
0.340
 Why?
Hyperparathyroidism, Secondary
1
2011
12
0.340
 Why?
Liability, Legal
1
2011
43
0.340
 Why?
Malpractice
1
2011
44
0.340
 Why?
Appointments and Schedules
1
2011
97
0.340
 Why?
Pyridines
2
2026
605
0.340
 Why?
Tomography, X-Ray Computed
3
2017
2730
0.330
 Why?
Patient Safety
2
2016
347
0.330
 Why?
Adaptive Clinical Trials as Topic
4
2024
24
0.330
 Why?
Influenza B virus
3
2025
47
0.330
 Why?
Risk Assessment
9
2025
3671
0.330
 Why?
Training Support
1
2010
36
0.330
 Why?
Dose-Response Relationship, Drug
4
2026
2027
0.330
 Why?
Parathyroid Hormone
1
2011
112
0.320
 Why?
Interleukin-6
2
2025
780
0.320
 Why?
Personnel, Hospital
2
2020
31
0.320
 Why?
Ambulatory Care
5
2023
600
0.320
 Why?
Inpatients
2
2021
545
0.320
 Why?
South Africa
4
2025
261
0.320
 Why?
Military Medicine
2
2022
149
0.320
 Why?
Digital Rectal Examination
1
2010
10
0.310
 Why?
Occult Blood
1
2010
40
0.310
 Why?
Blood Glucose
3
2008
2327
0.300
 Why?
Ambulances
3
2023
53
0.300
 Why?
Ukraine
2
2026
35
0.300
 Why?
Patient Care
1
2010
118
0.300
 Why?
Child
22
2024
22633
0.300
 Why?
Inflammation
1
2021
2878
0.300
 Why?
Intrauterine Devices
1
2009
29
0.300
 Why?
Urban Population
4
2025
491
0.290
 Why?
Seasons
7
2025
556
0.290
 Why?
Bias
3
2024
202
0.280
 Why?
Clinical Competence
4
2025
1244
0.280
 Why?
Cause of Death
2
2017
471
0.280
 Why?
Atracurium
2
2019
14
0.280
 Why?
Neuromuscular Blocking Agents
2
2019
26
0.270
 Why?
Masks
2
2025
70
0.270
 Why?
Socioeconomic Factors
5
2015
1326
0.270
 Why?
Mathematics
1
2008
100
0.270
 Why?
Morpholines
2
2026
128
0.260
 Why?
Body Mass Index
4
2019
2438
0.260
 Why?
Prevalence
7
2026
2834
0.260
 Why?
Immunization, Passive
2
2025
87
0.260
 Why?
Video Recording
6
2025
212
0.260
 Why?
Age Distribution
4
2014
403
0.250
 Why?
Medical Futility
2
2024
31
0.250
 Why?
Pulmonary Disease, Chronic Obstructive
3
2009
920
0.250
 Why?
Influenza A virus
2
2025
113
0.250
 Why?
Registries
4
2024
2385
0.250
 Why?
Immunization
2
2025
374
0.240
 Why?
Heart Arrest
3
2025
407
0.240
 Why?
Disease Models, Animal
1
2017
4557
0.240
 Why?
Informed Consent
2
2026
198
0.240
 Why?
Respiratory Syncytial Virus, Human
2
2026
81
0.240
 Why?
Data Collection
4
2014
633
0.240
 Why?
Ivermectin
2
2023
14
0.240
 Why?
Etomidate
1
2025
18
0.230
 Why?
Crush Injuries
1
2025
12
0.230
 Why?
Magnetic Resonance Imaging
2
2008
3863
0.230
 Why?
Pragmatic Clinical Trials as Topic
2
2026
133
0.230
 Why?
War-Related Injuries
1
2026
46
0.230
 Why?
Calcifediol
1
2025
31
0.230
 Why?
Emergency Treatment
3
2019
124
0.230
 Why?
Disclosure
1
2026
85
0.230
 Why?
Prochlorperazine
1
2025
10
0.230
 Why?
Community-Acquired Infections
2
2020
174
0.230
 Why?
Oseltamivir
1
2025
14
0.230
 Why?
Vasoconstrictor Agents
3
2024
144
0.230
 Why?
Multimorbidity
1
2026
63
0.230
 Why?
Decision Support Systems, Clinical
2
2021
265
0.230
 Why?
Anti-Bacterial Agents
6
2026
1907
0.220
 Why?
Renin
1
2024
34
0.220
 Why?
Point-of-Care Testing
1
2025
35
0.220
 Why?
Staphylococcal Infections
1
2009
388
0.220
 Why?
Vaccines, Synthetic
5
2022
138
0.210
 Why?
Hospitals, Urban
3
2016
144
0.210
 Why?
Bayes Theorem
2
2026
433
0.210
 Why?
Cyclopropanes
1
2024
83
0.210
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2024
103
0.210
 Why?
Glycocalyx
1
2024
30
0.210
 Why?
Ketamine
1
2025
132
0.210
 Why?
Acetates
1
2024
80
0.210
 Why?
Cognitive Dysfunction
2
2021
461
0.210
 Why?
Antibiotic Prophylaxis
1
2025
129
0.210
 Why?
Medical Audit
2
2018
77
0.210
 Why?
Glycine
1
2025
187
0.210
 Why?
Choice Behavior
2
2019
177
0.210
 Why?
Pregnancy Complications
1
2010
592
0.210
 Why?
Fluid Therapy
2
2023
147
0.210
 Why?
Altitude Sickness
1
2025
141
0.200
 Why?
Hypnotics and Sedatives
1
2026
216
0.200
 Why?
Incidence
4
2025
2879
0.200
 Why?
Chronic Disease
3
2022
1813
0.200
 Why?
Hypotension
2
2023
126
0.200
 Why?
Sulfides
1
2024
91
0.200
 Why?
Multiple Organ Failure
1
2024
124
0.200
 Why?
Physician-Patient Relations
1
2009
585
0.200
 Why?
United States Food and Drug Administration
1
2024
203
0.200
 Why?
Ambulatory Care Facilities
3
2020
265
0.200
 Why?
Diabetic Ketoacidosis
1
2006
210
0.200
 Why?
Disease Progression
5
2021
2847
0.200
 Why?
Androstadienes
1
2023
76
0.200
 Why?
Receptor, Angiotensin, Type 1
1
2023
25
0.200
 Why?
Immunocompromised Host
2
2022
201
0.190
 Why?
Lactams
1
2023
28
0.190
 Why?
Quinolines
1
2024
193
0.190
 Why?
Child, Preschool
12
2019
11787
0.190
 Why?
Electronics
1
2023
71
0.190
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2025
297
0.190
 Why?
Comorbidity
4
2021
1658
0.190
 Why?
Analgesics, Non-Narcotic
1
2024
123
0.190
 Why?
Lopinavir
1
2022
30
0.190
 Why?
Patient Acceptance of Health Care
2
2020
885
0.190
 Why?
RNA, Messenger
7
2023
2832
0.190
 Why?
Lung Injury
1
2025
237
0.190
 Why?
Leucine
1
2023
116
0.190
 Why?
Plasma
1
2024
225
0.190
 Why?
Proline
1
2023
83
0.180
 Why?
Health Services Research
2
2016
396
0.180
 Why?
Attitude of Health Personnel
1
2010
1185
0.180
 Why?
Equivalence Trials as Topic
1
2022
36
0.180
 Why?
Violence
1
2025
281
0.180
 Why?
Recovery of Function
3
2022
707
0.180
 Why?
Cytokines
2
2014
2061
0.180
 Why?
Delirium
1
2023
104
0.180
 Why?
Syncope
1
2022
55
0.180
 Why?
Blood Transfusion
1
2025
405
0.180
 Why?
Respiratory Syncytial Viruses
3
2025
58
0.180
 Why?
Urinary Tract Infections
1
2004
202
0.180
 Why?
Herpes Zoster Vaccine
1
2024
154
0.180
 Why?
Nitriles
1
2023
205
0.180
 Why?
Metformin
1
2025
318
0.180
 Why?
Immunization, Secondary
1
2022
91
0.170
 Why?
Veterans Health
1
2023
189
0.170
 Why?
Acetaminophen
1
2024
264
0.170
 Why?
Mountaineering
2
2025
36
0.170
 Why?
Immunization Programs
1
2023
194
0.170
 Why?
Long Term Adverse Effects
1
2021
13
0.170
 Why?
Malawi
1
2021
57
0.170
 Why?
Polypharmacy
1
2022
93
0.170
 Why?
Wounds, Penetrating
1
2022
72
0.170
 Why?
Vasodilator Agents
1
2023
331
0.170
 Why?
Cardiopulmonary Resuscitation
1
2025
340
0.170
 Why?
Sentinel Surveillance
3
2025
46
0.170
 Why?
Health Policy
1
2024
400
0.170
 Why?
Abdominal Pain
1
2022
146
0.170
 Why?
Drug Prescriptions
1
2003
284
0.170
 Why?
Work
1
2020
23
0.170
 Why?
Academic Medical Centers
4
2020
547
0.160
 Why?
Adrenergic beta-Agonists
2
2012
92
0.160
 Why?
Contact Tracing
1
2020
26
0.160
 Why?
Telecommunications
1
2020
20
0.160
 Why?
Quality of Health Care
3
2010
691
0.160
 Why?
Aftercare
1
2022
223
0.160
 Why?
Venous Thromboembolism
1
2025
324
0.160
 Why?
Data Interpretation, Statistical
3
2026
372
0.160
 Why?
Herpes Zoster
1
2024
315
0.160
 Why?
Burns
1
2025
377
0.160
 Why?
Hemorrhage
1
2025
809
0.160
 Why?
Rural Population
3
2016
650
0.160
 Why?
Chi-Square Distribution
3
2012
529
0.160
 Why?
Personnel Turnover
2
2010
42
0.160
 Why?
Abbreviated Injury Scale
1
2019
27
0.160
 Why?
Neuromuscular Blockade
2
2019
51
0.150
 Why?
Sensitivity and Specificity
3
2025
1985
0.150
 Why?
Iraq
1
2019
66
0.150
 Why?
Electrocardiography
1
2003
662
0.150
 Why?
Outpatient Clinics, Hospital
1
2020
80
0.150
 Why?
Pulmonary Embolism
2
2025
244
0.150
 Why?
Agkistrodon
1
2019
6
0.150
 Why?
Adrenal Cortex Hormones
5
2021
478
0.150
 Why?
Physical Therapy Modalities
1
2023
332
0.150
 Why?
Afghanistan
1
2019
96
0.150
 Why?
Hypoglycemic Agents
2
2025
1387
0.150
 Why?
Antivenins
1
2019
29
0.150
 Why?
Respiratory Insufficiency
1
2023
326
0.150
 Why?
Computer Simulation
1
2024
1025
0.150
 Why?
Snake Bites
1
2019
24
0.150
 Why?
Symptom Assessment
1
2020
137
0.150
 Why?
Infant
7
2019
10034
0.150
 Why?
Immunoglobulin Fab Fragments
1
2019
56
0.150
 Why?
Crotalid Venoms
1
2019
32
0.150
 Why?
Organ Transplantation
1
2022
247
0.150
 Why?
Continuity of Patient Care
2
2012
291
0.150
 Why?
Dantrolene
1
2019
5
0.150
 Why?
Neuromuscular Depolarizing Agents
1
2019
6
0.150
 Why?
Succinylcholine
1
2019
5
0.150
 Why?
Malignant Hyperthermia
1
2019
8
0.150
 Why?
Consensus
1
2021
488
0.150
 Why?
Lactic Acid
1
2020
302
0.150
 Why?
Muscle Relaxants, Central
1
2019
14
0.150
 Why?
Iraq War, 2003-2011
1
2019
173
0.140
 Why?
Quality Indicators, Health Care
2
2012
335
0.140
 Why?
Afghan Campaign 2001-
1
2019
195
0.140
 Why?
Postoperative Complications
2
2025
2919
0.140
 Why?
Injury Severity Score
2
2022
600
0.140
 Why?
Formative Feedback
1
2018
31
0.140
 Why?
Platelet-Rich Plasma
1
2018
41
0.140
 Why?
Renal Replacement Therapy
3
2025
100
0.140
 Why?
Needs Assessment
3
2010
404
0.140
 Why?
Vaccines
1
2023
389
0.130
 Why?
Hospitals, Teaching
2
2011
119
0.130
 Why?
Biological Specimen Banks
1
2018
102
0.130
 Why?
ROC Curve
3
2025
614
0.130
 Why?
Out-of-Hospital Cardiac Arrest
1
2019
124
0.130
 Why?
Survivors
1
2021
520
0.130
 Why?
Maryland
1
2017
66
0.130
 Why?
Time-to-Treatment
4
2021
243
0.130
 Why?
Civil Defense
1
2017
21
0.130
 Why?
Income
2
2008
202
0.130
 Why?
Neutrophils
2
2026
1134
0.130
 Why?
Cardiovascular Diseases
1
2009
2168
0.130
 Why?
Infusions, Intravenous
3
2024
423
0.130
 Why?
Specimen Handling
1
2018
186
0.130
 Why?
Assisted Living Facilities
1
2016
19
0.120
 Why?
Certification
3
2020
119
0.120
 Why?
Fibroblast Growth Factors
1
2018
188
0.120
 Why?
Oxygen Consumption
1
2019
724
0.120
 Why?
Avalanches
1
2016
2
0.120
 Why?
Trachea
3
2023
261
0.120
 Why?
Cognition
2
2023
1266
0.120
 Why?
Executive Function
1
2021
461
0.120
 Why?
Educational Status
2
2008
467
0.120
 Why?
Accidental Falls
2
2016
222
0.120
 Why?
Orthopedic Procedures
1
2018
243
0.120
 Why?
Environmental Exposure
1
2020
588
0.120
 Why?
AIDS Serodiagnosis
2
2012
23
0.110
 Why?
Advance Directives
1
2016
87
0.110
 Why?
Colitis, Ulcerative
1
2017
147
0.110
 Why?
Efficiency, Organizational
1
2016
139
0.110
 Why?
Stress Disorders, Post-Traumatic
1
2023
893
0.110
 Why?
Evidence-Based Medicine
2
2016
732
0.110
 Why?
Self Report
3
2025
872
0.110
 Why?
RNA, Viral
3
2024
688
0.110
 Why?
Predictive Value of Tests
3
2020
2115
0.110
 Why?
Aminopyridines
2
2026
127
0.110
 Why?
Awareness
1
2015
108
0.110
 Why?
Angiotensin I
2
2025
7
0.100
 Why?
Precision Medicine
1
2018
457
0.100
 Why?
Cost-Benefit Analysis
1
2017
634
0.100
 Why?
Frail Elderly
1
2015
134
0.100
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2017
248
0.100
 Why?
Proportional Hazards Models
2
2025
1325
0.100
 Why?
Infant, Newborn
3
2014
6429
0.100
 Why?
Hepatopulmonary Syndrome
1
2014
23
0.100
 Why?
Creatinine
1
2015
506
0.100
 Why?
Confidence Intervals
3
2010
333
0.100
 Why?
Fluvoxamine
2
2023
16
0.100
 Why?
Lipopolysaccharides
1
2017
863
0.100
 Why?
Health Care Costs
1
2017
427
0.100
 Why?
Risk
2
2017
911
0.100
 Why?
Patient-Centered Care
2
2016
544
0.100
 Why?
Feasibility Studies
3
2025
1095
0.100
 Why?
Perioperative Care
1
2016
231
0.100
 Why?
Delivery of Health Care
1
2020
947
0.100
 Why?
Pneumonia, Bacterial
1
2014
113
0.100
 Why?
Crohn Disease
1
2017
260
0.100
 Why?
Anesthesiology
1
2016
175
0.100
 Why?
Vaccines, Combined
2
2022
49
0.090
 Why?
Physician's Role
1
2014
218
0.090
 Why?
Headache
1
2013
150
0.090
 Why?
Immunization Schedule
2
2025
187
0.090
 Why?
Quality of Life
2
2025
3185
0.090
 Why?
Preventive Health Services
2
2012
152
0.090
 Why?
Neoplasms
1
2008
2875
0.090
 Why?
Quality Improvement
1
2021
1289
0.090
 Why?
Trauma Centers
2
2025
462
0.090
 Why?
Antigens, Viral
2
2024
182
0.090
 Why?
Hospital Costs
1
2013
124
0.090
 Why?
Immune System
1
2013
179
0.090
 Why?
Sampling Studies
1
2012
99
0.090
 Why?
Combined Modality Therapy
2
2019
1266
0.090
 Why?
Oregon
1
2011
76
0.090
 Why?
Georgia
1
2011
83
0.090
 Why?
Pyrimidines
2
2026
532
0.090
 Why?
Sex Distribution
2
2013
386
0.090
 Why?
Fractures, Bone
1
2016
414
0.090
 Why?
Massachusetts
1
2011
180
0.080
 Why?
Drug Administration Schedule
3
2019
779
0.080
 Why?
Epithelial Cells
1
2017
1125
0.080
 Why?
HIV
1
2012
250
0.080
 Why?
Professional Practice Location
1
2010
26
0.080
 Why?
Specialization
1
2011
136
0.080
 Why?
Statistics, Nonparametric
2
2009
427
0.080
 Why?
Patient Protection and Affordable Care Act
1
2011
102
0.080
 Why?
Legislation as Topic
1
2010
5
0.080
 Why?
Health Care Reform
1
2011
109
0.080
 Why?
Delegation, Professional
1
2010
1
0.080
 Why?
Viral Load
2
2023
526
0.080
 Why?
Medical Staff, Hospital
1
2010
80
0.080
 Why?
Albuterol
1
2010
73
0.080
 Why?
Emergency Nursing
1
2010
22
0.080
 Why?
Peptide Fragments
2
2025
699
0.080
 Why?
Occupations
1
2010
51
0.080
 Why?
Mice, Knockout
1
2017
3121
0.080
 Why?
Medically Underserved Area
1
2010
101
0.080
 Why?
Allied Health Personnel
1
2010
55
0.080
 Why?
Medical Order Entry Systems
1
2010
40
0.080
 Why?
Workload
1
2011
170
0.080
 Why?
Social Class
2
2009
268
0.080
 Why?
Altitude
1
2014
473
0.080
 Why?
Geriatric Assessment
1
2011
233
0.070
 Why?
Population
1
2009
30
0.070
 Why?
Mice, Inbred C57BL
2
2017
5992
0.070
 Why?
Motivation
2
2012
610
0.070
 Why?
Practice Patterns, Physicians'
1
2018
1356
0.070
 Why?
Forced Expiratory Volume
1
2010
449
0.070
 Why?
Interprofessional Relations
1
2011
281
0.070
 Why?
Schools, Veterinary
1
2008
3
0.070
 Why?
Specialty Boards
1
2009
42
0.070
 Why?
Algorithms
1
2017
1837
0.070
 Why?
Professional Role
1
2010
158
0.070
 Why?
Fatal Outcome
1
2009
307
0.070
 Why?
Nutritional Status
1
2011
354
0.070
 Why?
Interleukin-10
1
2010
309
0.070
 Why?
Disease Management
2
2011
645
0.070
 Why?
Mental Health Services
1
2014
473
0.070
 Why?
Drug Therapy, Combination
2
2021
1047
0.070
 Why?
Job Satisfaction
1
2010
240
0.070
 Why?
Smoking Cessation
1
2012
439
0.070
 Why?
Nurses
1
2010
178
0.070
 Why?
Device Removal
1
2009
143
0.070
 Why?
Mexican Americans
1
2009
114
0.070
 Why?
Glucocorticoids
2
2023
535
0.070
 Why?
Statistics as Topic
1
2008
284
0.070
 Why?
Health Status Indicators
1
2008
166
0.070
 Why?
Insulin
2
2009
2507
0.070
 Why?
Immunity, Innate
2
2014
846
0.060
 Why?
Glucose Tolerance Test
1
2008
361
0.060
 Why?
Morbidity
1
2008
323
0.060
 Why?
Mental Recall
2
2021
222
0.060
 Why?
Administration, Inhalation
2
2023
574
0.060
 Why?
Forecasting
1
2008
391
0.060
 Why?
Animals
4
2019
38058
0.060
 Why?
Liver Transplantation
1
2014
823
0.060
 Why?
Triazines
1
2026
49
0.060
 Why?
Virus Diseases
1
2008
216
0.060
 Why?
Indazoles
1
2026
80
0.060
 Why?
RNA
2
2023
940
0.060
 Why?
T-Lymphocytes, Regulatory
1
2009
389
0.060
 Why?
Geography
1
2006
203
0.060
 Why?
Hospitals, Community
1
2026
65
0.060
 Why?
Leukocyte Count
1
2026
316
0.060
 Why?
Anesthetics, Dissociative
1
2025
46
0.060
 Why?
Utah
1
2025
81
0.060
 Why?
History, 21st Century
1
2006
219
0.060
 Why?
Picolinic Acids
1
2025
8
0.060
 Why?
Anesthetics, Intravenous
1
2025
69
0.060
 Why?
Self Care
1
2008
389
0.060
 Why?
Papillomavirus Vaccines
1
2009
297
0.060
 Why?
Analysis of Variance
1
2008
1306
0.060
 Why?
History, 20th Century
1
2006
325
0.060
 Why?
Burn Units
1
2025
48
0.060
 Why?
Calcium
1
2011
1183
0.060
 Why?
Perioperative Period
1
2025
71
0.060
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2024
6
0.060
 Why?
Cannula
1
2025
27
0.050
 Why?
Staphylococcus aureus
1
2009
455
0.050
 Why?
Papillomavirus Infections
1
2009
345
0.050
 Why?
Triazoles
1
2026
184
0.050
 Why?
Germany
1
2025
138
0.050
 Why?
Leukotriene Antagonists
1
2024
23
0.050
 Why?
Pyridazines
1
2024
57
0.050
 Why?
Missouri
1
2004
66
0.050
 Why?
Feedback
1
2025
181
0.050
 Why?
Equipment Reuse
1
2024
18
0.050
 Why?
Lung
1
2017
4109
0.050
 Why?
Sample Size
1
2024
123
0.050
 Why?
Dyspnea
1
2025
251
0.050
 Why?
Prognosis
2
2020
4282
0.050
 Why?
Phentolamine
1
2023
20
0.050
 Why?
Vasoactive Intestinal Peptide
1
2023
20
0.050
 Why?
Angiotensins
1
2023
8
0.050
 Why?
Early Diagnosis
1
2024
249
0.050
 Why?
Patient Acuity
1
2023
47
0.050
 Why?
Shock
1
2024
108
0.050
 Why?
Vaccines, Attenuated
1
2024
129
0.050
 Why?
Qualitative Research
2
2022
1671
0.050
 Why?
Long-Term Care
1
2024
117
0.050
 Why?
Macrolides
1
2003
69
0.050
 Why?
Calibration
1
2023
151
0.050
 Why?
Cross-Over Studies
1
2025
601
0.050
 Why?
Angiotensin II
1
2023
97
0.050
 Why?
Nucleocapsid
1
2022
19
0.050
 Why?
Remission Induction
1
2023
307
0.050
 Why?
Sex Characteristics
1
2008
790
0.050
 Why?
Drug Repositioning
1
2022
41
0.050
 Why?
Information Dissemination
1
2024
223
0.050
 Why?
Advisory Committees
1
2024
228
0.050
 Why?
Immunity, Cellular
1
2024
272
0.050
 Why?
Emergency Medical Dispatch
1
2022
6
0.050
 Why?
Immunocompetence
1
2022
47
0.040
 Why?
Drug Combinations
1
2023
390
0.040
 Why?
Hemoglobins
1
2024
384
0.040
 Why?
Information Systems
1
2022
57
0.040
 Why?
Syndrome
1
2022
380
0.040
 Why?
Pulse Therapy, Drug
1
2021
7
0.040
 Why?
Oligopeptides
1
2023
269
0.040
 Why?
Health Promotion
2
2022
774
0.040
 Why?
Ligands
1
2023
673
0.040
 Why?
Infectious Disease Transmission, Professional-to-Patient
1
2020
5
0.040
 Why?
Intention to Treat Analysis
1
2020
80
0.040
 Why?
Transplant Recipients
1
2022
180
0.040
 Why?
Personnel Staffing and Scheduling
2
2011
98
0.040
 Why?
Antimalarials
1
2020
35
0.040
 Why?
Herpesvirus 3, Human
1
2024
336
0.040
 Why?
Personal Protective Equipment
1
2020
57
0.040
 Why?
Documentation
1
2022
198
0.040
 Why?
Seroepidemiologic Studies
1
2020
172
0.040
 Why?
Health Facilities
1
2021
85
0.040
 Why?
Asymptomatic Diseases
1
2020
102
0.040
 Why?
Vaccination Coverage
1
2021
103
0.040
 Why?
Models, Statistical
1
2024
681
0.040
 Why?
HIV Infections
2
2012
3154
0.040
 Why?
Single-Blind Method
1
2020
312
0.040
 Why?
Follow-Up Studies
1
2009
5408
0.040
 Why?
Recombinant Fusion Proteins
1
2022
675
0.040
 Why?
Ergocalciferols
1
2019
14
0.040
 Why?
Practice Guidelines as Topic
2
2022
1560
0.040
 Why?
Program Evaluation
1
2003
948
0.040
 Why?
Protein Kinase Inhibitors
1
2024
969
0.030
 Why?
Education, Medical, Graduate
1
2003
557
0.030
 Why?
Host-Pathogen Interactions
1
2021
371
0.030
 Why?
RNA Transport
1
2017
27
0.030
 Why?
Endothelium, Vascular
1
2024
965
0.030
 Why?
Controlled Before-After Studies
1
2017
15
0.030
 Why?
Myocardial Infarction
1
2025
1209
0.030
 Why?
Poly(ADP-ribose) Polymerases
1
2017
86
0.030
 Why?
Kaplan-Meier Estimate
1
2019
965
0.030
 Why?
Workflow
1
2018
184
0.030
 Why?
Africa
1
2017
116
0.030
 Why?
Pregnancy
1
2010
7190
0.030
 Why?
Historically Controlled Study
1
2016
5
0.030
 Why?
Gene Knockdown Techniques
1
2017
336
0.030
 Why?
Neuropsychological Tests
1
2021
1134
0.030
 Why?
Ghana
1
2015
43
0.030
 Why?
Cell Communication
1
2017
324
0.030
 Why?
Reimbursement, Incentive
1
2015
42
0.030
 Why?
Cathelicidins
1
2014
41
0.030
 Why?
Injections, Intravenous
1
2014
200
0.030
 Why?
Mortality
1
2017
375
0.030
 Why?
Antimicrobial Cationic Peptides
1
2014
86
0.030
 Why?
Muscle Strength
1
2017
330
0.030
 Why?
Clinical Coding
1
2013
25
0.020
 Why?
Depression
1
2023
1558
0.020
 Why?
Internet
1
2017
699
0.020
 Why?
Bed Occupancy
1
2011
16
0.020
 Why?
Nanoparticles
1
2017
519
0.020
 Why?
Domestic Violence
1
2011
51
0.020
 Why?
Salmeterol Xinafoate
1
2010
20
0.020
 Why?
Pamphlets
1
2010
26
0.020
 Why?
Resource Allocation
1
2010
53
0.020
 Why?
Tobacco Use Disorder
1
2012
218
0.020
 Why?
Demography
1
2010
288
0.020
 Why?
Consumer Health Information
1
2010
49
0.020
 Why?
Longitudinal Studies
1
2017
2947
0.020
 Why?
Self Efficacy
1
2012
414
0.020
 Why?
Psychometrics
1
2012
734
0.020
 Why?
Research
1
2011
431
0.020
 Why?
Teaching
1
2010
236
0.020
 Why?
Patient Satisfaction
1
2012
704
0.020
 Why?
Anti-Asthmatic Agents
1
2010
251
0.020
 Why?
Linear Models
1
2009
854
0.020
 Why?
Reproducibility of Results
1
2012
3409
0.010
 Why?
Ginde's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (655) concept(s)
_
Co-Authors Expand Description
See all (135) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)